European Partnership on Rare Diseases (ERDERA) (Phase 2)

About This Grant

European Partnership on Rare Diseases (ERDERA) (Phase 2). Call: Partnerships in Health (2026/1). Programme: HORIZON. Keywords: Anticancer therapy, Biobanks, Biomarkers, Cancer and its biological basis, Cardiac and Cardiovascular systems, Child health, Chronic diseases, Clinical data, Clinical information, Clinical management, Clinical medicine, Clinical neurology, Clinical research, Clinical targets, Clinical trials, Cohort studies, Collective Awareness Platforms, Comparative effectiveness research, Congenital heart disease, Degenerative diseases, Dermatology and venereal diseases, Electronic patient files, Endocrinology, Endocrinology and metabolism (including diabetes, hormones), Epidemiology, Ethics in medical sciences, Gene therapy, cell therapy, regenerative medicine, General and internal medicine, Genomics, comparative genomics, functional genomics, Global health, Haematology, Health care, Health care sciences and services (including hospital administration, health care financing), Health data, Health management systems, Health policies, Health policy and services, Health sciences, Health services, health care research, Health-related biotechnology, Healthcare system, Human genetics, Immunology, Integrated care, Interventional clinical trials, Medical biotechnology, Medical biotechnology related ethics, Medical statistics, Meta-analysis, Metabolism, biological basis of metabolism related disorders, Nephropathy, Neurodegenerative disorders, Neurological disorders (e.g. Alzheimer's disease, Huntington's disease, Parkinson's disease), Neuropathy, Neurosciences (including psychophysiology), Non-communicable diseases (except for neural/psychiatric and immunity-related), Oncology, Ophthalmology, Other clinical medicine subjects, Otorhinolaryngology, Paediatrics, Patient care, Patient stratification, Pediatric cardiology, Personalised medicine, Public health, Quality of health care, Quality-of-life, Rare diseases, Registries, Research integrity and research misconduct, Respiratory systems, Risk factors, Social biomedical sciences (includes family planning, sexual health, psycho-oncology, political and social effects of biomedical research), Social structure, inequalities, social mobility, interethnic relations, Technologies involving identifying the functioning of DNA, proteins and enzymes and how they influence the onset of disease and maintenance of well-being (gene-based diagnostics and therapeutic interventions (pharmacogenomics, gene-based, Technologies involving the manipulation of cells, tissues, organs or the whole organism (assisted reproduction), Tissue banks, Translational medicine, Transplantation, Urology and nephrology. Open call from the EU Funding & Tenders Portal.